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Abstract
A markedly reduced interest or pleasure in activities previously considered pleasurable is a main symptom in mood disorder 
and psychosis and is often present in other psychiatric disorders and neurodegenerative diseases. This condition can be 
labeled as “anhedonia,” although in its most rigorous connotation the term refers to the lost capacity to feel pleasure that 
is one aspect of the complex phenomenon of processing and responding to reward. The responses to rewarding stimuli are 
relatively easy to study in rodents, and the experimental conditions that consistently and persistently impair these responses 
are used to model anhedonia. To this end, long-term exposure to environmental aversive conditions is primarily used, and 
the resulting deficits in reward responses are often accompanied by other deficits that are mainly reminiscent of clinical 
depressive symptoms. The different components of impaired reward responses induced by environmental aversive events 
can be assessed by different tests or protocols that require different degrees of time allocation, technical resources, and 
equipment. Rodent models of anhedonia are valuable tools in the study of the neurobiological mechanisms underpinning 
impaired behavioral responses and in the screening and characterization of drugs that may reverse these behavioral deficits. 
In particular, the antianhedonic or promotivational effects are relevant features in the spectrum of activities of drugs used 
in mood disorders or psychosis. Thus, more than the model, it is the choice of tests that is crucial since it influences which 
facets of anhedonia will be detected and should be tuned to the purpose of the study.
Keywords: hedonic response, intracranial self stimulation, motivation, self administration, stress
Introduction
Anhedonia is listed in the DSM-5 (American Psychiatric 
Association, 2013) among the main schizophrenia negative 
symptoms, and it is defined as “the decreased ability to experi-
ence pleasure from positive stimuli or a degradation in the 
recollection of pleasure previously experienced.” Similar con-
cepts—loss of interest or pleasure, not feeling any enjoyment in 
activities that were previously considered pleasurable—are also 
reported among the main symptoms and criteria for the diagno-
sis of major depressive disorder (DSM-5, American Psychiatric 
Association, 2013). These symptoms are often associated with 
“social withdrawal.” The condition of anhedonia, that is, in its 
stricter connotation, the loss of feeling pleasure, is the disrup-
tion of just one facet in a complex reward-processing phenom-
enon that encompasses pleasure expectation, reward evaluation, 
determination of the effort necessary to obtain it, and planning 
and deciding the appropriate strategy to repeat the pleasurable 
experience. A deficit in any of these aspects in the reward process 
may result in behaviors that could be interpreted as “anhedonia.” 
For instance, the expression “a degradation in the recollection 
of pleasure previously experienced” refers to pleasure-triggered 
cognitive processes codified in brain areas and by mechanisms 
very likely different from those underpinning pleasure percep-
tion (Der-Avakian and Markou, 2012), and this is true either 
for the recollection of a previous pleasurable experience or for 
its degradation. Thus, although several authors strongly sus-
tain that the definition of anhedonia should be restricted to a 
well-defined neurobiological construct (Berridge and Robinson, 
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the term is often used both in the clinical evaluation of patients 
and in basic science experimental contexts in a broader 
connotation.
Anhedonia can be studied in its different aspects in humans 
and in nonhuman animals, ranging from different mamma-
lian species, even productive animals (Figueroa et al., 2015), to 
zebrafish, the new promising, complementary model organism 
(Fontana et al., 2018). However, rodents are still the species most 
commonly used (Ellenbroek and Youn, 2016). Rewards of a differ-
ent nature can be used to examine and experimentally dissect 
in its components the response to rewarding stimuli. Food is a 
stimulus very frequently used, since it is fairly easy to manipu-
late and the confounding variables can be identified and con-
trolled with reasonable effort. Thus, this review will focus on 
rodent models and responses in different tests mainly to food 
stimuli.
Taste Hedonic and Food Intake
In animal studies, the most frequently used approach to evaluate 
the competence to experience pleasure is the sucrose preference 
test (Figueroa et  al., 2015; Willner, 2017a), while the pattern of 
orofacial taste responses elicited by the consumption of palat-
able foods, including sucrose, is used as an index of the hedonic 
value of gustatory stimuli (Grill and Norgren, 1978). There is gen-
eral agreement that pleasure perception is mainly mediated by 
μ-opiod (MOR) and endocannabinoid receptor stimulation in 
different brain areas, whereas the information encoded in mes-
olimbic dopamine neurons plays a central role in reward motiv-
ational value and motivational salience (Hajnal and Norgren, 
2005). In striatal areas, MOR stimulation is considered to confer 
hedonic value in rodents and/or humans to different rewarding 
stimuli, including opiate drugs, palatable food, social interaction, 
music/art, sex, humor, and monetary gain (Haber and Knutson, 
2010; Ikemoto, 2010), whereas a phasic increase in extraneu-
ronal dopamine is believed to confer incentive salience to pleas-
urable stimuli (Berridge, 2007). That is, in striatal areas a single 
pleasurable stimulus may activate at the same time 2 distinct 
neurotransmitter systems with distinct yet concurrent influ-
ence on the development of the hedonic response. Morphine 
and opioid peptides have potent stimulatory effects on food 
intake (Morley et al., 1983; Hoebel, 1985; Reid, 1985) and opioid 
peptides are remarkably effective at driving food intake and/or 
enhancing taste hedonics from specific subcortical sites, notably 
the nucleus accumbens (NAc), the central nucleus of the amyg-
dala, and the ventral pallidum (Baldo and Kelley, 2007; Smith and 
Berridge, 2007). Experiments using caloric and noncaloric palat-
able foods led to the conclusion that the hyperphagia induced by 
MOR stimulation in the NAc is independent of the caloric value 
of tastants and is associated with the suppression of satiety sig-
nals inhibiting food intake (Katsuura et al., 2011). Thus, a theory 
that has received considerable support through the years is that 
opioids specifically regulate palatability, that is, the pleasurable 
or “hedonic” aspects of food stimuli (Berridge, 1996).
Gustative and Hedonic Pathways
In rodents, the first central gustatory relay is the nucleus of the 
solitary tract that projects rostrally to the pontine parabrachial 
nuclei (PBN) (Lundy and Norgren, 2004). From the PBN, 2 gusta-
tory pathways arise: the first projects to the ventroposterome-
dial thalamic nucleus (the thalamic taste area), which in turn 
sends efferents to the primary gustatory cortex, and represents 
the sensory pathway for taste (Lundy and Norgren, 2004). The 
second, the hedonic pathway, distributes widely in the hypo-
thalamus and the ventral forebrain including the amygdala 
and the bed nucleus of the stria terminalis (Lundy and Norgren, 
2004), and in turn these PBN target areas send axons to the shell 
portion of the NAc (NAcS) and the ventral tegmental area (VTA) 
(Lundy and Norgren, 2004). Thus, PBN is not merely a sensory 
relay station, but it also plays an important role in integrating 
various ascending and descending inputs (Hajnal and Norgren, 
2005). Interestingly, MORs are already involved in pleasure per-
ception after palatable food consumption at the level of the PBN 
(Wilson et al., 2003).
Early seminal studies have demonstrated that the gustatory 
value (i.e., the palatability) of sucrose, or glucose, is concentra-
tion dependent (Davis, 1973) and food deprivation dependent 
(Booth, 1972). Thus, both the increased sweetness and the caloric 
deficit increase the hedonic value of a palatable food. However, 
experiments carried out in chronically decerebrate rats outline 
a substantial difference between these 2 factors. Chronically 
decerebrate rats, in which neural connections between the 
forebrain and the brainstem are severed, maintain only the pro-
gressive strengthening of the gustatory response to increasing 
concentrations of sugar (Kaplan et al., 2000; Lundy and Norgren, 
2004). The absence of food deprivation-induced increase in 
gustatory value in the decerebrate animal preparation (Kaplan 
et al., 2000) suggests the existence of an interplay between the 
PBN and the forebrain in mediating this effect in intact animals. 
Thus, the pure perception of the gustatory value of a palatable 
food seems to be restricted to the condition of non-food depriva-
tion, as fasting superimposes a modulation of palatability at the 
forebrain level. From this perspective, the clear-cut distinction 
between feeling pleasure (“hedonic responses”) and pleasure 
expectation, reward evaluation, and determination of the effort 
necessary to obtain it can only be hypothesized and tested in 
rigorous experimental settings, but it is probably quite blurred 
in a “real life” context.
Dopaminergic Signaling and Hedonic Motivation
Consumption of palatable foods, including sucrose, increases 
extraneuronal dopamine levels in the NAc, and this effect is con-
centration dependent for sucrose solutions (Hajnal et al., 2004). 
The PBN plays a central role in the control of NAc dopamine 
levels via its extensive connections to the ventral forebrain, and 
specific lesions in the PBN hedonic pathway abolish the sucrose-
induced increase of dopamine levels in the NAc (Hajnal and 
Norgren, 2005). Although the role of dopamine in reward remains 
controversial (Salamone, 2003), dopaminergic activity, particu-
larly in the mesolimbic system, does increase when normally 
preferred stimuli are encountered (Wise, 2002). Thus, phasic 
increases in extraneuronal dopamine levels in the NAcS are 
used as an index of the reward value of a sucrose stimulus. Such 
transient increases in extraneuronal dopamine modify dopa-
minergic signaling in striatal areas as essentially they stimulate 
the low-affinity dopamine D1 receptors, while the high-affinity 
dopamine D2 receptors are already stimulated by basal levels of 
extraneuronal dopamine (Nakanishi et al., 2014). Palatable food 
consumption-induced increase in extraneuronal dopamine lev-
els in the NAcS confers incentive salience to the food stimulus 
(Berridge, 2007). This phasic increase in NAcS dopamine levels 
is associated in rats with consistent dopamine D1 receptor-
sustained modifications in the phosphorylation pattern of some 
cAMP-dependent protein kinase (PKA) substrates such as the 
dopamine and cAMP-regulated phosphoprotein of Mr 32 000 
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modifications in the phosphorylation levels of the Thr34 resi-
due of DARPP-32 consistently correlate with phasic modifica-
tions in NAcS extraneuronal dopamine levels (Danielli et  al., 
2010). Similarly to what was reported for NAcS dopamine levels, 
modifications in the phosphorylation levels of Thr34 DARPP-32 
in response to palatable food consumption are blunted in rats 
exposed to a chronic unavoidable stress paradigm that induces 
a condition of “motivational anhedonia,” detected as a reduced 
performance in sucrose self-administration protocols (Marchese 
et  al., 2013; Scheggi et  al., 2017b). Moreover, the modifications 
in the phosphorylation levels of Thr34 DARPP-32 in response to 
palatable food consumption and the motivation to operate in 
sucrose self-administration schedules show slightly, yet con-
sistently, distinct patterns according to the feeding condition of 
the animal (Danielli et  al., 2010; Scheggi et  al., 2013, 2018). In 
the medium spiny neurons of striatal areas, dopamine D1 recep-
tors are predominantly coexpressed with MORs (Chartoff and 
Connery, 2014), and while MORs are coupled with a Gi/o protein 
and inhibit adenylyl cyclase activity, the dopamine D1 receptor 
activates the PKA signaling cascade through a Gs protein. The 
transduction systems of the 2 receptors are then in functional 
competition in the neurons where they are coexpressed, yet 
they may also concur to elicit common effects (Scheggi et  al, 
2009). In fact, in neurons of the cortex and striatum that express 
both receptors, the MOR can form stable heteromeric complexes 
with the dopamine D1 receptor (Juhasz et al., 2008). Moreover, in 
mice acute MOR receptor stimulation elicits the formation of a 
β-arrestin2-mediated signaling complex that results in activa-
tion of dopamine D1 receptor signaling in the NAc (Urs et  al., 
2011). A condition of mild food deprivation in rats increases the 
levels of β-arrestin2-dependent heteromeric complexes of MOR-
dopamine D1 receptors in the NAcS, and in food-deprived rats 
the observed sucrose-induced increase in dopamine D1 receptor 
signaling is β-arrestin2-dependent in this area (Scheggi et  al., 
2017a). The observation that a mild food deprivation induces a β-
arrestin2-mediated increase in dopamine D1 receptor signaling 
upon MOR stimulation by endogenous opioid peptides released 
in response to sucrose highlights how complex the interplay 
can be between the neuronal systems that subserve the dif-
ferent components of the reward response and that can be dif-
ferently affected in conditions of broadly defined “anhedonia.” 
Thus, a cautious approach is probably warranted when studying 
the phenomenon of anhedonia and the neurobiological systems 
underpinning its behavioral manifestations in animal models.
Models and Tests
An animal model of a psychiatric disorder can be defined as a 
construct that, inducing abnormal animal behaviors, aims to 
reproduce relevant phenotypic aspects of mental disorders. In 
particular, according to the National Institute of Mental Health 
Research Domain Criteria initiative that encourages the identi-
fication and treatment of specific behavioral symptoms (Insel 
et  al., 2010), animal models should be developed and used to 
assess specific behavioral domains more than an entire psychi-
atric syndrome (Der Avakian and Pizzagalli, 2018; Slattery and 
Cryan, 2017), and “positive valence systems” is the domain that 
includes dimensions of reward processing (Cuthbert and Insel, 
2013). However, with regard to animal models of depression, the 
term “model” is often employed to describe the methods used 
to assess depressive-like behaviors (tests) as well as the pro-
tocols that induce the depressive-like phenotype. The distinc-
tion between a “model” and a “test” is an important one as the 
“model” is the complex phenotypic construct that can only be 
revealed by “tests” of depressive-like responses (van der Staay, 
2006; Cryan and Slattery, 2007; Cryan and Sweeney, 2011; Kara 
and Einat, 2013; Belzung, 2014; Slattery and Cryan, 2017). On the 
other hand, a test employed outside the context of a model, that 
is, in a “normal” animal, is of limited value as it assesses the nor-
mal behavioral repertoire of the species, or strain, in response to 
the challenge (represented by the specific test applied) (Belzung, 
2014). Since the risk of developing a depressive disorder con-
sistently increases in subjects exposed to repeated adverse life 
events (DSM-5, American Psychiatric Association, 2013), animal 
models based on chronic exposure to stress protocols are widely 
used to study the behavioral and neurobiological modifications 
that develop under these conditions, in the assumption that 
these may be a correlate of the human disorder (Slattery and 
Cryan, 2017). In addition to stress models that relay on environ-
mental stressors and have been defined “exteroceptive,” “intero-
ceptive” stress models are also used that involve detection of 
“stressors” (proinflammatory mediators) from the internal envi-
ronment (Sawchenko et al., 2000; Stepanichev et al., 2014).
Tests are then used to assess the validity of the model and 
the potential effect of a treatment. The two key domains usually 
tested in animal models of depression are reactivity to aversive 
stimuli (behavioral despair, hopelessness, or helplessness) and 
anhedonia (Figure  1). Several models of depression based on 
repeated stress exposure, including the chronic unpredictable 
mild stress (CMS), social defeat, and early-life stress protocols 
(Bolton et al., 2018), can induce a condition of “anhedonia,” even 
though not all of these models, or not consistently, also induce 
behavioral despair (reviewed in Duman, 2010). In these models, 
face validity is provided by the development of depressive-like 
behaviors following a long-term exposure to stressors that is 
reminiscent of the chronic course of depression and by the find-
ings that long-term but not acute antidepressant administra-
tion usually relieves anhedonia (Papp et  al., 1996). Behavioral 
despair is primarily assayed in rodents by exposure to inescap-
able stressors, such as those used in the tail-suspension test 
(TST) in mice or forced-swimming test (FST) in mice and rats, 
and it is quantified as the proportion of time spent perform-
ing escape-related behaviors relative to time spent immobile, 
which is interpreted as a sign of behavioral despair or passivity 
(Porsolt et al., 1977; Steru et al., 1985). Reward-related measures 
are often used in animal models of depression since anhedonia, 
in its broad definition, is a core symptom of depression that can 
be assessed in rodents. In fact, rodents attribute hedonic value 
to a variety of stimuli that are also endowed with hedonic value 
for human beings, such as palatable foods (mainly sweets, e.g., 
sucrose or saccharin), social and sexual interactions, and drugs 
of abuse, and they will actively work to obtain these stimuli. 
These behavioral responses to reward are impaired in rodents 
by exposure to chronic stress protocols, and they should be res-
cued by established or novel clinically useful antidepressant 
and/or antianhedonic treatments. Different approaches can be 
used to measure hedonic responses in rodents, from the largely 
used and relatively simple-to-perform sucrose preference test 
to the more technically and time-demanding, and invasive 
intracranial self-stimulation (ICSS) protocol, and the behavioral 
modifications observed are in general responsive to antidepres-
sant treatments (Willner et  al., 1987; Zacharko and Anisman, 
1991). However, one must keep in mind that sucrose preference 
test, ICSS, and other tests, for example, the conditioned place 
preference (CPP) test, measure the behavioral response of the 
animal to a reward, and the interest in reward and the levels 
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Models
The Chronic Mild Stress Model
The CMS model derives from the studies published in the early 
1980s by Katz and colleagues, in which rats were exposed to a 
sequence of different severe stressors, and stress effects were 
assessed using as readouts changes in open field behavior that 
were specifically reversed by repeated treatment with anti-
depressant drugs (Katz et al., 1981). Moreover, rats exposed to 
this stress protocol did not increase their fluid consumption 
when saccharin or sucrose was added to the drinking water, sug-
gesting that this might indicate a decreased perceived hedonic 
value of the sweet solution (Katz, 1982). This hypothesis was 
then supported by the demonstration that exposure to uncon-
trollable foot-shocks elicits a decrease in ICSS behavior in mice, 
suggesting disturbances of motivational/reward processes that 
could be blunted by antidepressant administration (Zacharko 
and Anisman, 1991). These results stimulated the development 
of a model of stress-induced anhedonia. The model that was 
developed and validated uses stressors that can be defined as 
mild compared with the severe stressors used in the Katz stud-
ies and that have an ecological validity, representing possible 
environmental adverse situations (Willner, 2017a). The intense 
impact of the protocol on behavior derives from the exposure 
to an unremitting and unpredictable sequence of mild stress-
ors that continues over several (5–9) weeks (Willner, 2017a). 
Rodents exposed to this protocol develop a pattern of behavioral 
modifications that may be considered as correlates of clinical 
symptoms of depression, in particular a decreased response to 
rewards (Figure 1). The CMS protocol has been adapted to mice 
(Monleon et al., 1995) and is today widely used in this species 
(Willner, 2017a). In the original version of the model, reward sen-
sitivity is assessed by repeated tests before and during stress 
exposure in which the animal is given access to a palatable 
sweet solution (consumption test), or has the choice between a 
sweet solution and water (preference test). Consumption of, or 
preference for, the sweet reward decreases with exposure to the 
CMS protocol, but it can be restored to normal levels by long-
term administration of different classes of antidepressant drugs 
(Willner, 2017a). The rationale for considering the CMS-induced 
decrease in sucrose intake or preference as a sign of anhedonia 
is based on the assumptions that consumption of a palatable 
sweet solution can be considered an index of the sensitivity to 
reward and that CMS exposure has a pervasive effect on the sen-
sitivity to reward, rather than a selective effect on the response 
to sweets. This latter assumption is supported by the findings 
that CMS exposure also increases the threshold for ICSS in the 
VTA (Moreau et al., 1992) and impairs the development of CPP 
for different natural or pharmacological reinforcers (Papp et al., 
Figure 1. Rodent models of depression/anhedonia and behavioral tests used to evaluate reactivity toward aversive (a) and positive stimuli (b). The figure represents 2 
of the most commonly used models that induce depressive- and anhedonic-like behaviors in rodents (chronic mild stress and chronic social defeat) and the behavioral 
tests primarily applied to these models to evaluate the reactivity toward aversive (a, behavioral despair) and rewarding stimuli (b, anhedonia). The chronic mild stress 
model of depression relies on a series of mild physical stressors that are presented in an unpredictable sequence for 5 to 9 weeks. The chronic social defeat model relies 
on an innate social behavior in adult male rodents that show a strong motivation to defend their territory (resident) against an unfamiliar male (intruder). The stronger 
resident predictably defeats the intruder and a stable dominant/subordinate relationship is formed. In the chronic protocol, the intruder is periodically subordinated 
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1991). However, a criticism to the first assumption is that anhe-
donic depressed patients may sometimes evaluate sweet tastes 
as less pleasant (e.g., Steiner et  al., 1993), but more often the 
response to sweet tastes is not affected in depressed patients 
(e.g., Dichter et  al., 2010). Since its first description, the CMS 
model has become one of the most frequently utilized models 
of depression and anhedonia. However, today many research 
teams use protocols of chronic exposure to sequences of mild 
stressors that differ, slightly or substantially, from the classical 
protocol and are labeled chronic unpredictable stress, unpre-
dictable chronic stress, CMS, unpredictable chronic mild stress, 
and chronic varied or variate stress. A  recent review shows 
that different names of the model do not strictly relate to the 
severity of the stressors used or predictability of the stressors 
(Willner, 2017a), and they usually yield similar results than the 
original protocol.
Despite its use in laboratories around the world and the 
recognition of its validity, the CMS model is often criticized for 
the lack of reproducibility of its effects. However, results from 
a recent survey of a large sample of users indicate that the 
CMS model is regarded as “generally reliable within, and robust 
across laboratories” (Willner, 2017b). The reliability of the model 
seems to be mainly influenced by few factors that should be 
carefully considered when planning to use it: the individual dif-
ferences in the vulnerability to stressors, within and between 
rodent populations; the stressors used, which should be suf-
ficiently intense to induce a stress response and sufficiently 
variable in their patterns of presentation to prevent the devel-
opment of habituation; and the use of good laboratory practices, 
which are crucial when the sucrose test is the main outcome 
measure (Willner, 2017b). Individual differences in susceptibil-
ity to CMS in relation to strain differences have been demon-
strated in mice between the more resilient DBA/2 and C57BL/6 
and the more susceptible BALB/c strains (Griffiths et al., 1992; 
Farley et al., 2012). In rats, increased susceptibility to CMS has 
been reported for the Flinders Sensitive Line or Wistar-Kyoto 
strains (Pucilowski et al., 1993). Moreover, different susceptibility 
to CMS has also been reported among outbred Wistar rats from 
different suppliers (Theilmann et  al., 2016). The variability in 
susceptibility to CMS within populations of animals of the same 
strain is usually regarded as a problem. However, the possibility 
to identify subgroups of CMS-susceptible and CMS-resilient rats 
or mice can be considered as an advantage since it allows the 
study of the neurobiological mechanisms underlying stress sus-
ceptibility and resilience (e.g., Couch et al., 2013; Nieto-Gonzalez 
et al., 2015; Rossetti et al., 2016).
Social Defeat or Social Stress
Animal models of social defeat stress have been developed based 
on the behavioral response of adult male rodents (residents) that 
show a strong motivation to defend their territory against unfa-
miliar males (intruders), such that a stronger resident-animal 
predictably defeats the intruder animal (Olivier and Mos, 1992). 
Thus, the experimental animal (the intruder) exposed to an 
ethological stressor, the aggressive socially dominant resident, 
develops specific behavioral modifications (mainly submissive 
behaviors) that are reminiscent of symptoms, such as anhedo-
nia, social avoidance, despair, and anxiety, common to a num-
ber of psychiatric disorders including depression, posttraumatic 
stress disorder, and psychosis. The classical resident-intruder 
paradigm is based on dyadic agonistic encounters between 
adult male conspecifics and usually consists of a phase of physi-
cal contact during which the intruder is placed in the cage of 
the aggressive resident and exposed to its attacks, and a phase 
of sensory contact during which the intruder is in visual, audi-
tory, and olfactory contact with the dominant resident, but it is 
protected from physical contact, to maintain a condition of psy-
chological stress. Social defeat is defined as the intruder display-
ing submission signs (upright and sidewise posture, avoidance, 
fleeing, and freezing behavior) for a defined amount of time 
and the resident showing aggressive behavior (attack, escalated 
fight, chasing, rushing, and biting) (Kudryavtseva et  al., 1991). 
Usually the physical interaction between the aggressive resident 
and the intruder lasts for a fixed period of time, or until defeat 
is observed, whichever presents first, when the experimenter 
intervenes to prevent severe physical injuries immediately after 
observing the established defeat criteria (Tornatzky and Miczek, 
1993; Berton et al., 2006). The resident-intruder test is the classi-
cal paradigm of acute social stress and the model of social defeat 
is the chronic extension of this test. Exposure to social conflict 
in chronic protocols typically lasts from 10 (Berton et al., 2006) 
to 40 days (Bartolomucci et al., 2001). The most frequently used 
resident-intruder protocols are the chronic psychosocial stress 
model (Bartolomucci et al., 2001) and the chronic social defeat 
stress model (Berton et al., 2006), and, despite some differences 
in the experimental procedures, both protocols result in “social 
defeat.” A different model that uses the resident-intruder pro-
tocol is the social defeat-induced persistent stress paradigm 
that consists of a short exposure to social defeat (5 encounters) 
followed by long-term exposure (2–3  months) to social isola-
tion, a subthreshold stressor (Von Frijtag et al., 2000). The social 
defeat-induced persistent stress model is characterized by a 
long-lasting, anhedonic-like phenotype with social withdrawal 
and impaired processing of reward stimuli (Riga et al., 2015). In 
the social defeat model, animals show marked individual differ-
ences in their susceptibility or resilience to develop anhedonic-
like behavior after chronic defeat (Der-Avakian et al., 2014), and 
these differences are more common in this model compared 
with the CMS model. The tests used to assess the behavioral 
consequences of chronic social defeat explore the domains of 
social behaviors (social avoidance), anhedonia, and reactivity 
toward aversive stimuli (Figure 1).
Immune-Mediated Models
An intricate interplay exists between the brain and the immune 
system and bi-directional communications between these 
apparently distinct systems have been implicated in the regu-
lation of mood (Dantzer et  al., 2008; Stepanichev et  al., 2014). 
Depressed patients show increased levels of inflammatory 
markers in the periphery and brain, including interleukin 
(IL)-1β, IL-6, and tumor necrosis factor-α and T-cell activation 
markers (Dowlati et al., 2010; Maes, 2011). On the other hand, 
several inflammatory diseases or medical conditions that lead 
to chronic inflammation (e.g., cardiovascular diseases and type 
2 diabetes) have a high co-morbidity with depression (Benton 
et  al., 2007), and patients who undergo immunotherapy with 
interferon-alpha have an increased risk for developing depres-
sive symptoms (Raison et al., 2006; Udina et al., 2012). Evidence 
indicates that stressors can activate the immune-inflammatory 
system and social experiences modulate such activation, exac-
erbating or reducing proinflammatory responses and mood dis-
orders (Dantzer et al., 2008; Stepanichev et al., 2014). These data 
encouraged preclinical studies to investigate whether in stress-
induced animal models of depression/anhedonia increases in 
immune-inflammatory system activation markers accompa-
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induction of an immuno-inflammatory response resulted in 
development of anhedonia and depressive-like behaviors. In 
different animal models of depression, inflammation and cell-
mediated immune activation accompany the development of 
depressive-like behavioral responses, and antidepressant drugs 
that positively affect behavior also affect different markers of 
immuno-inflammation (Maes, 2011). In rats, exposure to the 
CMS protocol is accompanied by increased expression of pro-
inflammatory cytokines IL-1β, IL-6, and markers and mediators 
of microglia activation, paralleled by a reduction of transform-
ing growth factor-β expression (Rossetti et  al., 2016). The sig-
nificance of these results is supported by the selective increase 
in immuno-inflammatory markers in rats showing reduced 
sucrose intake in the sucrose consumption test, but not in 
resilient animals (Rossetti et al., 2016). A recent study in mice 
shows that exposure to a chronic social stress protocol activates 
the immune-inflammatory system in the periphery and in the 
VTA-NAc dopaminergic pathway, reducing mesolimbic dopa-
minergic transmission (Bergamini et al., 2018). At the behavioral 
level, defeated mice show a decrease in operant responding for 
sucrose in tests validated as sensitive assays for NAc dopamin-
ergic activity, thus suggesting a possible mechanism for a causal 
correlation between immuno-inflammatory activation and 
anhedonic-like behaviors (Bergamini et al., 2018). Recent clinical 
and preclinical studies suggest that vulnerability to increased 
immune-inflammatory stimuli after a significant stress could be 
related to impaired integrity of the brain blood barrier around 
the NAc and may represent the link between stress exposure 
and development of depressive symptoms (Cooper et al., 2018).
In rodents, immune activation elicited by immune chal-
lenges, for example with the peripheral induction of cytokines 
by administration of bacterial lipopolysaccharide (LPS), induces 
an increase in proinflammatory cytokines also in the brain in 
regions such as the hippocampus and prefrontal cortex (Dantzer 
et al., 2008; Stepanichev et al., 2014; Jaehne et al., 2015), accom-
panied by a behavioral syndrome with a distinct time course 
that includes depression-like traits. In the first hours after the 
challenge, animals show what is defined “sickness behavior,” 
characterized by fever, reduced food and water intake, reduc-
tion of locomotor and exploratory activity, and decreased social 
interaction (Dantzer et al., 2008; Stepanichev et al., 2014). Then, 
when the sickness behavior wanes, animals show a depressive-
like phenotype, with anhedonia and behavioral despair (Dantzer 
et al., 2008; Painsipp et al., 2011; Jaehne et al., 2015). The obser-
vations that repeated antidepressant treatments attenuate 
some of the behavioral effects of immune challenge, such as 
decreased preference for sweet solutions and social interactions 
and decreased reactivity to aversive stimuli (Dantzer et al., 2008; 
Stepanichev et al., 2014), support the validity of immune-medi-
ated models. Moreover, some second-generation antipsychotic 
drugs have been tested for their potential effects on LPS-
induced neuroinflammation and behavioral impairments with 
conflicting results. The repeated administration of quetiapine or 
its metabolite norquetiapine before the LPS challenge induces 
a favorable balance in the levels of some pro- and antiinflam-
matory cytokines in the periphery and brain 4 hours after the 
challenge. However, this effect is not observed at 24 hours, when 
a lack of activity was also observed on LPS-induced decreased 
preference for a sweet solution (Jaehne et al., 2015).
An important bias in these experimental models is the 
occurrence of cytokine-induced sickness behavior that is 
characterized by a behavioral repertoire partially superim-
posable to depressive-like behaviors. The reduced food intake 
also causes decreased consumption of palatable foods that 
mimics anhedonia, while the reduced motor activity mimics 
the increase in immobility in tests of behavioral despair, such as 
the forced swimming and tail suspension tests (Dantzer et al., 
2008). Thus, in these models specific depressive-like behavioral 
responses should be observed in immune-stimulated rodents 
independently of sickness-related impairments in performance, 
and this involves an accurate choice of doses and time intervals 
for the assessments. In mice, a dissociation between nonspe-
cific, sickness-induced decreases in locomotor activity and food 
and water intake and, respectively, depressive-like behavioral 
responses in the FST and TST and in the sucrose preference 
test has been demonstrated by testing animals at the peak of 
the sickness syndrome (6 hours) and at 24 hours, when sick-
ness was expected to be minimal (Frenois et al., 2007). Moreover, 
in rats, the administration of the proinflammatory cytokine 
IL-1β impairs effort-related choice behavior at doses that do not 
reduce food intake or affect preference for the highly palatable 
pellets and do not increase core body temperature (Nunes et al., 
2014). These results indicate that carefully designed experimen-
tal models are useful tools to investigate the possible role of 
proinflammatory cytokines in different aspects of anhedonia, 
consummatory or motivational, such as anergia and fatigue.
Responses to LPS challenge are influenced by several factors. 
A recognized factor is the genetic background, as Fawn-Hooded 
rats, that show some of the behavioral traits of a depressive-like 
phenotype are more sensitive than Sprague-Dawley rats to IL-1β 
-induced immobility in the FST (Dantzer et al., 2008) and different 
mouse strains show different vulnerability to immune challenge 
(Painsipp et al., 2011; Stepanichev et al., 2014). The psychosocial 
context is another relevant factor in modulating responses to 
immune activation, and thus housing (single vs group housing) 
or sex may influence the effects observed (Frenois et al., 2007; 
Painsipp et al., 2011; Stepanichev et al., 2014). Another variable 
that influences responses to immuno-challenge is the age of 
animals. Inconsistent results have been reported on long-term 
behavioral consequences of immuno-challenges performed pre-
natally or at early stages of postnatal development (Stepanichev 
et al., 2014), while aging is associated with increased immune 
system activation, with an enhanced production of proinflam-
matory cytokines in the brain. Aged mice respond to LPS chal-
lenge with a higher brain inflammatory response accompanied 
by a more severe sickness behavior and depressive-like behavior 
compared with younger adults (Godbout et al., 2008).
Tests
Reactivity Toward Aversive Stimuli: Behavioral 
Despair
The FST and TST were developed, and are still frequently used, 
to test the efficacy of antidepressant drugs on the behavioral 
despair induced by acute exposure to the test itself (Porsolt 
et al., 1977; Steru et al., 1985). In these tests, behavioral des-
pair is defined as increased immobility or decreased latency to 
immobility. The tests can also be used to assess the reactivity 
toward aversive stimuli in models of depression/anhedonia. 
Increased immobility in the FST has been reported following 
CMS, immune-mediated models, or acute and chronic social 
defeat in rats (Rygula et al., 2005; Becker et al., 2008). In mice, 
however, effects of social defeat exposure on the FST and TST 
are not consistently found (Kinsey et al., 2007; Krishnan et al., 
2007). The FST, which measures the immobility that a rodent 
displays when immersed in a beaker filled with water from 
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compounds with potential antidepressant activity (Porsolt 
et  al., 1977). The FST has become a popular test frequently 
used for identifying potential antidepressant compounds and 
assessing the induction of a depressive phenotype in chronic 
models, with the anthropomorphical assumption that immo-
bility in the test represents a facet of depression. However, 
when using and interpreting the FST, we should also remem-
ber that a switch from active to passive behavior in response 
to the acute stressor (forced swim) is the expression of an 
adaptive response, based on learning processes, that increases 
the chances of survival (Molendijk and de Kloet, 2015; Olney 
et al., 2018).
Tests for the Assessment of Anhedonia
As highlighted in the Introduction, the reward process involves 
multiple components that can be dissected experimentally, but 
are likely intermingled in real life situations: (1) the sensory 
detection of the stimulus, (2) the affective hedonic reaction, 
pleasure itself (liking), (3) the motivation to obtain the reward 
and work for it (wanting or incentive salience), and (4) the 
reward-related learning processes. In many studies of chronic 
stress models, the consumption of, and/or preference for, sweet 
solutions is used as a measure of gustatory hedonic behavior in 
rodents. Such tests, initially used in the CMS model, were then 
applied to the chronic social stress models (Rygula et al., 2005). 
Social defeat induces anhedonia, assessed as sucrose prefer-
ence, only after long-term exposure (10 days or longer) (Yu et al., 
2011), but not after a single defeat episode (Razzoli et al., 2011) 
or a shorter exposure (Von Frijtag et al., 2002), similar to what 
was observed in the CMS model, where anhedonia is usually 
evident after 3 to 4 weeks of stress exposure (Willner, 2017a). In 
immune-mediated models, such as those induced by LPS or IL 
administration, the development of anhedonia is often assessed 
by measuring the consumption or preference for sweet solutions 
(Stepanichev et  al., 2014), but protocols probing motivational 
effort-related aspects of anhedonia for sweet rewards have also 
been successfully used (Nunes et al., 2014).
Social Interaction Test
Social motivation is a powerful drive of human behavior, and 
the disruption of social motivational mechanisms can represent 
a primary deficit (Chevallier et al., 2012). Accordingly, the Autism 
Spectrum Disorder can be regarded as an extreme case of early-
onset diminished social motivation, or social reward deficit 
(social anhedonia) (DSM-5, American Psychiatric Association, 
2013). Among social behaviors, sexual activity is highly reward-
ing for humans and animals (Trezza et al., 2011) since it induces 
a condition of well-being, pleasure, motivation, and associative 
learning (Berridge and Kringelbach 2008); a decrease in sexual 
drive is often seen in depressed patients. Like humans, mice 
and rats are social species and display a wide repertoire of 
social behaviors, engaging in reciprocal social interactions, par-
enting and mating behaviors, social play among juveniles, scent 
marking and aggressive behaviors, and behavioral assays have 
been developed to assess the aspects of sociability in rodents 
(Trezza et  al., 2011). Diverse place conditioning paradigms are 
available that rely on the rewarding nature of social interactions, 
such as CPP induced by social play behaviors in juvenile ani-
mals, pup interactions in postpartum dams, interactions with 
conspecific in adult rodents, and sexual behavior (Trezza et al., 
2011). However, the test most commonly used to assess impair-
ments in social reward processing is the social interaction test 
(Figure 2d). In rodent models, stress-exposed animals spend sig-
nificantly less time in proximity to a social target compared with 
control animals in a social interaction test (Berton et al., 2006), 
and the response to this test is used to distinguish susceptible 
from resilient animals. However, although chronic exposure to 
social defeat stress quite consistently results in social avoid-
ance or decreased social approach in a variety of tests to meas-
ure social behavior (see Hammels et al., 2015), the influence of 
CMS or other chronic unavoidable stress protocols on social 
Figure 2. Schematic representation of some of the behavioral tests used to assess deficits in the responses to reward in rodents. In the hedonic taste reactivity test (a), 
affective reactions to a palatable sucrose solution are measured. In the sucrose consumption or preference test (b), the choice between a sweet solution and water is 
determined. In the conditioned place preference protocol (c), the preference for the chamber where the rewarding stimulus was previously presented compared with 
the neutral chamber is evaluated. In the social interaction test (d), the amount of time spent in proximity to a social compared with an inanimate target is determined. 
In the intracranial self stimulation protocol (e), the operant behavior that allows animals to self-stimulate specific regions in the brain reward circuitry by pressing 
a lever or turn a wheel is evaluated. In the sucrose self-administration protocol (g), the operant behavior that allows animals to self-administer a palatable food by 
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behavior is less consistent and has been explored to a lesser 
extent (D’Aquila et al., 1994). Conversely, social deficits charac-
terize the behavioral phenotype of immune-mediated models 
(Stepanichev et al., 2014). The test has also been used to evalu-
ate the ability of an intra VTA acute or short-term optogenetic 
stimulation to change the condition of susceptibility to resil-
ience in mice, thus elucidating cellular mechanisms and neural 
circuits specifically involved in determining individual reactivity 
to a chronic social stress (Chaudhury et al., 2013; Friedman et al., 
2014). A decrease in sexual activity, or sexual drive, has also been 
described in rodents after exposure to CMS (D’Aquila et al., 1994; 
Grønli et  al., 2005). Moreover, impairments in sexual behavior 
are considered an index of anhedonia in other animal models 
of depression, such as the Flinders Sensitive rats (Ferreira-Nuño 
et al., 2002).
Female Urine Sniffing Test
The female urine sniffing test is a nonoperant protocol that 
measures reward-seeking behavior in rodents and is based 
on the interest in pheromonal odors from the opposite sex 
(Makelsman et al., 2010). In mammals, sexual activity is a pri-
mary stimulus and sexual behavior-associated chemosensory 
cues play a crucial role in social communication and in orient-
ing behavior and affecting physiology. The rewarding value of 
sniffing estrus female urine by male rodents is supported by 
the ultrasonic vocalizations emitted in the presence of females 
or elicited by exposure to urinary pheromones (Wysocki et al., 
1982). The test has 3 phases: a 3-minute exposure to a cotton 
tip dipped in sterile water; a 45-minute interval (no cotton tip 
is presented); and a 3-minute exposure to a cotton tip dipped 
in fresh urine collected from estrus females of the same strain. 
Sniffing duration is measured during exposure to water and 
female urine exposure (Malkesman et  al., 2010). Exposure to 
female urine is accompanied by emission of ultrasonic vocali-
zations and increased dopamine levels in the NAc compared 
with levels during water exposure, supporting the rewarding 
value of the chemosensory cue (Malkesman et  al., 2010). The 
tests has been validated in different strains of mice and in rats, 
and exposure to different stress models reduces the duration of 
female urine sniffing (Malkesman et al., 2010).
The advantages of the test are that it is simple and not time 
consuming. Moreover, it allows the evaluation of spontane-
ous reward-seeking behaviors and is not affected by possible 
impairments in taste, motor activity, or learning and memory 
processes. The limitations of the female urine sniffing test are 
that the response can be affected by pharmacological or genetic 
manipulations that impair olfactory system functions, or the 
sex hormone system may be dysfunctional in the model animal. 
Estrus female pheromonal odors also represent a social stimu-
lus and a more general decrease in social motivation reduces 
female urine sniffing (Wersinger et al. 2004). Finally, the test has 
been developed for male rodents and has not yet been adapted 
to female testing.
Hedonic Taste Reactivity
Anhedonia, in its most narrow meaning, is considered to reflect 
a condition of reduced liking that can be regarded as the affect-
ive expression of pleasure in response to a sensory reward 
(Figure 2a). Liking reactions to sweet taste can be measured in 
rodents since they show affective facial expressions of taste 
pleasure (“liking”) (Berridge, 1996). After consumption of a 
sweet solution (generally a sucrose solution), facial expressions, 
and patterns of licking are recorded in rats or mice and affect-
ive responses are scored. Hedonic responses include rhythmic 
midline and lateral tongue protrusions and paw licks. On the 
other hand, gapes, head shakes, face washes, forelimb flails, 
and chin rubs observed after exposure to unpleasant tastants 
are considered aversive responses, while passive dripping of 
solution out of the mouth, ordinary grooming, and rhythmic 
mouth movements are neutral responses. The licking behavior 
is also considered an index of hedonic response to reward, as 
the size of licking bouts is positively related to the palatability 
of the solution (Berridge, 2000). In an individual animal, totals 
of affective reactions are calculated for hedonic vs aversive cat-
egories by adding all response scores within an affective cat-
egory (hedonic, aversive, and neutral). To examine the hedonic 
sensitivity to sensory rewards, the taste reactivity (TR) test is 
employed, which is considered to measure the hedonic value 
attributed to stimuli. In the TR test, a solution is presented to the 
animal and the oral facial reactions to that tastant are assumed 
to reflect its palatability. Palatable sucrose solutions elicit 
hedonic TR behaviors (rhythmic and lateral tongue protrusions), 
whereas aversive quinine solutions elicit aversive TR behaviors 
(e.g., gapes). Hedonic-appetitive and aversive taste reactions are 
highly conserved, and similar oral facial affective responses are 
seen in human infants, adult primates, and rodents. The TR test 
has been originally developed for rats by Grill and Norgren (Grill 
and Norgren, 1978) and the complete procedure is detailed in 
(Wilmouth and Spear, 2009). The hedonic TR test has also been 
used to identify and characterize the hedonic “hot spots,” mainly 
in the NAc and ventral pallidum, where local microinfusions of 
opioid agonists or manipulations of the endocannabinoid sys-
tem increase liking reactions and/or food consumption (Richard 
et al., 2013). On the other hand, the hedonic TR test is seldom 
used as readout of anhedonia in animal models, since it is hardly 
affected by pharmacological manipulations, in particular of the 
dopaminergic system (Berridge and Robinson, 1998; Berridge, 
2000; Pardo et al., 2015) or by exposure to anhedonia-inducing 
protocols. However, we observed a reduction in hedonic TR 
responses in “anhedonic” cocaine-sensitized rats (Scheggi et al., 
2011) and in rats exposed to a 21-day chronic unavoidable stress 
protocol (Gambarana et al., 2003); both these chronic conditions 
are characterized by low baseline dopamine levels and blunted 
dopaminergic response to sucrose in the NAcS. Another reason 
for a limited interest in the use of this test in the characteriza-
tion of animal models or in the study of the response to antian-
hedonic treatments is that clinical evidence suggests that “taste 
anhedonia” does not play a relevant role in the reduced positive 
affect reactivity of depressed or psychotic patients.
Sucrose Consumption/Preference Test
The consumption of, or the preference for, palatable sweet solu-
tions, sucrose or saccharin, is the most frequently used test to 
measure sensitivity to reward in rodents. Animals can choose 
between a palatable sweet solution and plain water (Figure 2b). 
Thus, the decreased consumption of, or preference for, palatable 
solutions that can be observed after CMS or chronic social defeat 
exposure is considered to reflect a condition of “hedonic defi-
cit,” or anhedonia (Willner, 1997; Slattery et al., 2007; Krishnan 
and Nestler, 2011). This test is considered as a readout of liking 
because the decrease in sucrose consumption is not related to 
the caloric content and does not reflect a general decrease in 
consummatory behavior (Willner, 1997). Sucrose intake is cor-
rectly calculated as the amount of consumed sucrose in milli-
grams per gram body weight, while the preference for sucrose is 
calculated as the percentage of consumed sucrose solution over 
the total amount of liquid intake and is a more reliable meas-
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anhedonia in the sucrose preference test is usually a preference 
for sucrose <65%, based on studies that demonstrate that mice 
and rats with a sucrose preference <65% also showed increased 
threshold for ICSS (Moreau et al., 1992), decreased latency and 
increased duration of REM sleep (Cheeta et  al., 1997), reduc-
tion of sexual activity (D’Aquila et al., 1994), and alterations of 
circadian rhythms (Solberg et al., 1999). Thus, the criterion for 
anhedonia measured as a decrease in sucrose preference (con-
summatory anhedonia) is typically fulfilled by rodents that 
also show behavioral and physiological modifications that can 
be considered as correlates of symptoms and signs of depres-
sion and contribute to define a depressive-like syndrome. Mice 
and rats that reach this criterion are considered anhedonic and 
sensitive to the stress model. The animals exposed to the stress 
model that show a sucrose preference >65% are considered non-
anhedonic and resilient to the stress.
The advantages of the test, which explain its popularity in 
laboratories throughout the world, are that it is not technically 
demanding or time-consuming, and possible modifications in 
motility, anxiety, and learning induced by the exposure to one of 
the stress models do not significantly affect the response in the 
test. The disadvantages are the variability in the results obtained 
in different laboratories, or the low reproducibility in the same 
laboratory, often related to low adherence to good laboratory 
practices (size of the bottles, accuracy in removing and placing 
again the bottles in the cage, frequency of switching position of 
the bottles, etc.) (Strekalova et al., 2004). Moreover, a recent study 
demonstrated that the standard practice of handling mice by 
their tails, as opposed to tunnel handling, decreases responses 
to reward in terms of sucrose consumption and licking bouts 
(Clarkson et al., 2018). Thus, careful attention to details should 
be paid when performing the sucrose test, and one should be 
aware that even common laboratory practices can influence 
the affective state of experimental animals and their responses 
to the test. Important factors that can influence the test out-
come are the duration of the test, food and water deprivation, 
and concentration of the sucrose solution. Factors not strictly 
related to the hedonic state (e.g., interindividual differences in 
the pattern and amount of liquid intake, neophobia in animals 
naive to sucrose) are more likely to influence sucrose intake 
when the test lasts only a few hours, while they have a lesser 
impact in a 24-hour test. Circadian pattern in fluid and calories 
intake will also have a lesser impact on a 24-hour test. Food and 
water deprivation represents an acute stressor that affects the 
test, and when applied for many hours (e.g., 24 hours), it adds 
to the purely hedonic nature of the sucrose solution a caloric 
value. Thus, food and water deprivation, albeit frequently used, 
may represent a confounding factor (Strekalova et al., 2004). The 
concentration of sucrose solutions also represents a relevant 
variable as a U-shaped curve is often observed in rodent prefer-
ence for sweet solutions (Willner, 2017b). Exposure to stressors 
reduces in rodents the consumption of diluted sucrose solu-
tions, while it increases consumption of concentrated solutions 
(Willner, 1997). Similar results have also been obtained in pigs 
exposed to repeated social or restraint stress, suggesting con-
served stress influences on consummatory hedonic responses 
(Figueroa et  al., 2015). Furthermore, a sucrose solution has a 
caloric content, and with increasing sucrose concentration the 
likelihood of metabolic influence on intake increases. Thus, a 
1% sucrose solution is often used, especially in 24-hour tests, as 
its consumption is more sensitive to stress exposure and less 
sensitive to motivational manipulations, such as food depriva-
tion, than the consumption of more concentrated solutions. The 
caloric content of the sweet solution influences the assessment 
of consummatory anhedonia as exposure to a stress protocol 
does not reliably affect intake or preference for a sweet solution 
when a noncaloric saccharin solution (0.1% saccharin) is used, 
and the effect of stress exposure on saccharin intake appears 
to be dependent upon the duration of water deprivation that 
preceded the test (e.g., Harris et  al., 1997; Grønli et  al., 2005). 
Another possible factor that may influence the test outcome is 
that a loss in body weight can be observed in rodents exposed 
to a chronic stress protocol (more often in the CMS than in the 
social defeat model). A reduction in body weight is accompanied 
by a reduction in caloric needs that will affect sucrose intake. 
Sucrose intake is then more reliably calculated as the amount 
of consumed sucrose per gram body weight. Rodents may also 
show a side preference in drinking behavior that can affect the 
test outcome (Strekalova et al., 2004). For this reason, the posi-
tion of the water and sucrose solution bottles is switched during 
the test. However, a frequent switch of the bottles may represent 
a subtle stressor for the animals and may increase the error in 
measuring the amounts consumed since few drops may be lost 
at every change of position (Strekalova et al., 2004).
Conditioned Place Preference
The CPP protocol evaluates the preference of an animal between 
2 distinct environments: one where a stimulus was previously 
presented and the other where it was not (Bardo and Bevins, 
2000) (Figure 2c). The protocol is based on classical (Pavlovian) 
conditioning, as neutral environmental cues (conditioned 
stimuli) can evoke approach behavior when they are repeat-
edly paired to a rewarding stimulus (unconditioned stimulus). 
CPP can be induced by natural rewarding stimuli (e.g., food or 
positive social interactions) or by psychoactive drugs, and it is 
often used as a first step in the assessment of the abuse liabil-
ity of a compound. In experimental models of anhedonia, the 
preference for the environment paired with a reward (often 
a palatable food) can be evaluated. The CPP apparatus has 2 
chambers with distinctive features (color and pattern of the 
wall, floor characteristics) separated by a small intermediate 
area. Rodents are exposed for several days to the freely avail-
able palatable food in one chamber, alternated with exposure 
to the other empty chamber. On the test day, they are free to 
explore the whole apparatus and are tested for side preference 
in the absence of the reward (Figure 2). Animals not exposed to a 
stress model show an increased preference for the environment 
where a reward was received (paired with the reward), while 
stressed animals show a reduced or abolished preference. This 
effect can be reversed by long-term antidepressant administra-
tion, as originally shown by Willner and colleagues in the CMS 
model (Papp et al., 1991). Although this protocol was suggested 
to assess the incentive motivation to obtain a reward, the inter-
pretation that the performance of stressed animals in the CPP 
may result from a failure in reward reinforcement learning has 
also been proposed (Huston et al., 2013). CPP can also be induced 
by positive social interactions, such as sexual behavior, social 
play, or maternal behavior (Trezza et al., 2011). Social-CPP (SCPP) 
has been used to assess social anhedonia in a genetic model, the 
Disrupted-in-schizophrenia-1-Q31L mutant mouse, that shows 
decreases in monoamines content, in levels of β-arrestin-1,2 
and CREB, and in spine density in the NAc (Lipina et al, 2013). 
Pair-bonding among cagemates is rewarding in adult mice that 
acquire SCPP, but not in mutant mice that have deficits in social 
hedonic responses. Interestingly, bupropion repeated treatment 
eases the anhedonic behaviors in Disrupted-in-schizophrenia-
1-Q31L mutant mice, allowing SCPP acquisition, while desipra-
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These results support the role of the mesolimbic dopaminergic 
system in social rewards processing (Lipina et al, 2013). However, 
protocols based on social rewards are less frequently used when 
characterizing a model of anhedonia or studying the efficacy of 
a treatment. Psychoactive drugs induce CPP, but in the context 
of anhedonia models the results reported are quite variable, as 
they are influenced by the class of the drug used, the dose and 
pattern of administration, the species, and the construct of the 
model.
Intracranial Self-Stimulation
ICSS is an operant procedure in which rodents can self-stim-
ulate specific brain regions in the reward circuitry (e.g., pos-
terior lateral hypothalamus, medial forebrain bundle, VTA) 
through chronically implanted electrodes. Animals learn to 
press a lever or turn a wheel to receive the electrical stimula-
tion (Figure 2e), and acquisition of the task is almost immediate 
in normal animals. Responding in ICSS protocols is sensitive to 
manipulations that affect reward, as the stimulation threshold 
is reduced in conditions that facilitate reward and is increased 
in conditions characterized by anhedonia, such as withdrawal 
from drugs of abuse or depression models. In particular, in the 
CMS model, an increased ICSS threshold and a reversal of this 
effect by antidepressant treatment has been described in rats 
(Moreau et al., 1992), albeit not all the studies successfully repro-
duced these results (Nielsen et  al., 2000). In the social defeat 
model, susceptible rats show increased ICSS threshold imme-
diately after defeat, and this increase continues throughout the 
stress protocol and can be still observed 3 weeks after the end 
of stress exposure (Der-Avakian et al., 2014). In contrast, resil-
ient rats show an immediate increase in ICSS threshold, but 
the threshold quickly returns to baseline despite chronic expo-
sure to social defeat (Der-Avakian et al., 2014). Moreover, only in 
subgroups of susceptible rats did the ICSS threshold return to 
baseline after repeated antidepressant treatments (Der-Avakian 
et al., 2014). Exposure of mice to a chronic social defeat protocol 
elicits an increase in ICSS threshold that is maintained during 
social stress exposure and persists for 5 days after the end of 
the stress protocol (Donahue et al., 2014). The same study also 
showed that mice overexpressing ΔFosB in striatal dopamine 
D1 receptors expressing medium spiny neurons that are less 
susceptible to the effects of chronic social stress exposure on 
social avoidance are also less vulnerable to stress effect on ICSS 
thresholds (Donahue et al., 2014). The acute administration of 
ketamine to susceptible mice positively affects social avoidance 
but not the increase in ICSS threshold, suggesting that distinct 
neural circuits are involved in the regulation of distinct behavio-
ral responses (Donahue et al., 2014).
A relevant advantage of ICSS compared with food self-
administration is that responding is not influenced by satiation 
or stress-induced anxiety, and the response rate increases with 
the intensity of the stimulation, usually in terms of increase in 
the frequency (Hz) of the stimulus. Moreover, in well-trained 
animals, the stimulation threshold is quite constant and allows 
longitudinal evaluations of the effects of exposure to long-term 
stressors and/or treatments (Carlezon and Chartoff, 2007). The 
distinct responses on ICSS protocols of susceptible and resilient 
animals underscore the almost unique advantage of this pro-
cedure that allows the longitudinal study of the development 
of anhedonia, its consolidation only in susceptible populations, 
and the possible effects of treatments (Der-Avakian et al., 2014). 
Moreover, performance in ICSS protocols is considered a meas-
ure of motivation but also of the rewarding value of a stimu-
lus, and for this reason it is still regarded as the gold standard 
assay to determine the abuse liability of a compound (Rizvi 
et al., 2016). The disadvantages are that the ICSS procedure is 
invasive and technically demanding, and it is not a reasonable 
first choice in screening studies of new molecules with potential 
antidepressant and/or antianhedonic effects. Moreover, perfor-
mance in ICSS protocols is influenced by possible impairments 
in motor activity, learning, and memory processes.
Self-Administration
Several protocols have been developed to study motivational 
processes in animal models by examining behaviors aimed 
at obtaining natural rewards, such as food. The motivation to 
obtain a reward can be determined, for example, by protocols 
that measure how eagerly the animal runs for the reward in a 
runway (Ghiglieri et al., 1997; Pecina et al., 2003; Grappi et al., 
2011) or by food self-administration protocols, as rodents can 
be trained to operate, usually to press a lever, to self-administer 
a palatable food (Figure 2). The palatable food is often sucrose, 
and even rats that are not food deprived can be easily trained 
to operate for it. In self-administration protocols, the schedule 
used to assess the motivation to work for a natural (or a drug) 
reward is commonly the progressive ratio (PR) schedule (Hodos, 
1961) where increasing effort is required to obtain the reward as 
the ratio requirement progressively increases, and the last ratio 
completed is the breaking point. The breaking point measures 
the effort the animal is willing to exert to obtain the reinforc-
ing stimulus and is then considered an index of motivation, 
or of the perceived reinforcing value of the stimulus. Thus, a 
decrease in breaking point may be regarded as a core symptom 
in animal models of anhedonia, although this decrease is not 
reliably observed in all the models. Reductions in breakpoints 
for sucrose have been reported in a genetic animal model of 
depression, the congenital learned helpless rat (Vollmayr et al., 
2004), in a chronic unavoidable stress protocol in rats (Marchese 
et al., 2013; Scheggi et al., 2016), and in rats and mice exposed 
to chronic social defeat (Bergamini et al., 2016; Spierling et al., 
2017). This index of reduced motivation for a natural reward can 
be restored to control values by treatments endowed with anti-
depressant and/or promotivational activity, for example, lith-
ium, clozapine, aripiprazole, and lamotrigine (Marchese et  al., 
2013; Scheggi et al., 2015, 2017b; Scheggi, Pelliccia, De Montis and 
Gambarana, unpublished data). Conversely, exposure to the CMS 
model does not usually affect sucrose breaking point.
Possible confounding factors can affect response in the PR 
schedule; for example, satiety may reduce the motivation to 
work for further calories, the progressively increasing response 
requirement causes increasing time intervals between reward 
availability and may induce decreased breakpoints, overtrain-
ing may switch the goal-directed behavior into a habit that is 
no longer sensitive to the value of the reward (Balleine and 
Dickinson, 1998), or a reduced locomotor performance may 
nonspecifically impair responding. Moreover, it is still a debated 
issue what the breaking point actually measures since it is dif-
ficult to dissociate the motivational from the hedonic aspects of 
responding in a PR schedule as the manipulations used to mod-
ulate 1 of the 2 aspects of the reinforcer (e.g., food deprivation 
to increase motivation and different sucrose concentrations to 
vary the hedonic properties) actually affect both. Since motiva-
tion translates into action whereas the hedonic experience of 
the stimulus does not require action, operating for reward in a 
PR schedule is largely regarded as a measure of motivation. As 
previously noted, we tend to infer “liking” from a choice the ani-
mal makes or from the willingness to operate to obtain a stimu-
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not know whether a stimulus does or does not retain hedonic 
properties for the animal that stops responding in the PR sched-
ule (Der-Avakian et al., 2016; Kissileff and Herzog, 2018). Thus, as 
suggested in the Introduction, the 2 aspects that sustain behav-
ioral responses toward primary rewards are closely intertwined. 
Of relevance for these responses, in medium spiny neurons of 
the NAcS, a similar, strict relationship seems to link the opioid 
and dopaminergic transmissions. Limitations to the use of self-
administration protocols are the time required for training the 
animals, which may encompass some weeks, and the depend-
ence on conserved competence to perform required responding 
and learn the tasks.
Effort-Related Choice Behavior Tasks
Motivation has an activation component that plays a crucial role 
in the adaptive response of an organism to different impedi-
ments that are obstacles to the attainment of relevant stimuli. 
Symptoms related to impaired behavioral activation and effort-
related motivational aspects (e.g., anergia, fatigue, lassitude, loss 
of energy, and psychomotor retardation) are present in different 
psychiatric and nonpsychiatric disorders, including depression, 
schizophrenia, and parkinsonism (Salamone et  al., 2007). In 
animals, effort-based decisions and energy allocation in goal-
directed actions are based on evaluation of effort-related costs 
and motivational value of the stimulus (Salamone and Correa, 
2012). The mesolimbic dopamine system plays a crucial role 
in the neural circuitry that mediates behavioral activation and 
effort-related processes (Salamone et al., 1997, 2007; Salamone 
and Correa, 2012).
To study effort-related choice behavior (or effort-related, or 
effort-based decision-making) in experimental animals, sev-
eral protocols have been developed based on the possibility for 
the animal to choose between a high-valued reward requiring 
a high-effort instrumental response and a lo-valued reward 
requiring a low effort (Salamone et al., 2007, 2016). The degree of 
effort requirement that favors the choice of the smaller reward 
is related to the level of motivation/energy of the animal, and 
decreased motivation is measured as reduced willingness to 
work for greater rewards compared with control animals. The 
FR5/chow-feeding protocol is an operant task where rats can 
choose between lever pressing in a FR5 schedule to obtain a 
palatable food (high-carbohydrate pellets) or approaching and 
consuming a freely available but less preferred food (standard 
laboratory chow) (Salamone, 1991). In this task, rats usually 
obtain most of their food by lever pressing in the FR5 sched-
ule and consume only little amounts of standard chow. Another 
protocol is the T-maze barrier choice task (Salamone et  al., 
1994), where animals can choose between the 2 arms that con-
tain different densities of reward (e.g., different number of food 
pellets, or some pellets vs no pellet) and different effort require-
ments, usually the access to the higher reinforcer density arm 
is hindered by a barrier. A third protocol is the PR/chow-feeding 
concurrent choice task that takes advantage of effort discount-
ing procedures: rats can choose between lever pressing in a PR 
schedule to obtain the palatable high-carbohydrate pellets or 
approaching and consuming the freely available but less pre-
ferred standard food (Randall et al., 2012). Behavioral responses 
in these tasks are extremely sensitive to decreases in dopamin-
ergic transmission such that administration of low doses of 
dopamine antagonists or reductions in accumbens dopamine 
levels significantly shift the choice behavior increasing selection 
of the low-effort/low-reward choices (Salamone, 1991; Salamone 
et al., 2007, 2016).
These effort-related choice protocols are used to assess 
impairments in motivational activation in models of depres-
sion/anhedonia and to test the possible positive effect of dif-
ferent treatments. Deficits in effort-related decision-making 
have been observed in an immune-mediated model induced 
by IL-1β administration (Nunes et al., 2014) and are elicited by 
acute stress exposure (Shafiei et  al., 2012). Administration of 
tetrabenazine, an inhibitor of the vesicular monoamines trans-
porter type-2 that at low doses mainly depletes dopamine in 
striatal areas, selectively shifts choice behavior in a FR5/chow-
feeding task (Nunes et al., 2013), in a T-maze barrier choice task 
(Yohn et al., 2015), and in a PR/chow-feeding choice procedure 
(Salamone et al., 2012). Moreover, tetrabenazine administration 
decreased accumbal extracellular dopamine levels and dopa-
minergic signaling mediated by dopamine D1 and D2 receptors 
in terms of phosphoThr-34 and phosphoThr75-DARPP-32 levels 
(Nunes et  al., 2013). In line with these results, administration 
of bupropion, a catecholamine uptake blocker that increases 
extracellular dopamine and norepinephrine levels, reverses the 
impairments in effort-related behavior induced by tetrabena-
zine administration (Nunes et al., 2013). In depressed patients, 
deficits in effort-related motivational aspects are relevant symp-
toms often resistant to antidepressant treatments (Fava et al., 
2014). For these reasons, tests of effort-related decision-making 
have been translated to human studies in the effort expendi-
ture for rewards task (Treadway et al., 2009) and, when applied 
to populations of depressed individuals (Treadway et al., 2012; 
Yang et al., 2014) or psychotic patients with a preponderance of 
negative symptoms (Gold et al., 2015), demonstrated decreased 
preference for the higher reward requiring high effort.
Translational Tasks to Assess Reward-Related Process
Translational tasks have been developed to evaluate different 
aspects of anhedonia (reward learning, motivation, reward valu-
ation, and affect) in humans and experimental animals. The goal 
is to obtain preclinical tests as identical as possible to the clin-
ical tests to reliably predict clinical outcomes and facilitate the 
development of effective treatments for reward-related symp-
toms. Thus, although it is possible to develop and use transla-
tional behavioral assessments, this is not an easy task and some 
relevant aspects should be carefully considered, as discussed 
by Der-Avakian and Pizzagalli (2018). In particular, challenging 
issues that should be considered are: (i) the inherent differences 
between the brief instructions given before the test to a human 
subject and the long training necessary in animals; (ii) the qual-
ity of the reinforcers (usually extrinsic reinforcers are used in 
humans, e.g., monetary rewards, while intrinsic reinforcers are 
used in animals, e. g., food); (iii)  the stimuli chosen that should 
be selected based on the most acute sensory modalities of the 
species, and thus often differ between human and animals. 
Moreover, the validity of the behavioral task is increased when 
biological or physiological assessments are performed dur-
ing the test (Der-Avakian and Pizzagalli, 2018), although it is 
extremely difficult to use imaging techniques in a performing 
animal, and the invasive biological and physiological procedures 
used in animals cannot be used in humans. Another relevant 
aspect of translational tasks is the evaluation of the effects of 
pharmacological manipulations on the response to the test. 
Drug administration should be carefully planned to be analo-
gous in humans and nonhuman animals, in terms of doses, 
timing, and route of administration, considering the pharma-
cokinetic characteristics of the compound in the diverse species 
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Translational behavioral tests developed for use in humans 
and rodents include: (1) probabilistic reward learning tasks, 
in which the subject should learn that a behavioral response 
results in reward delivery with a certain probability and then 
adapt behavior to maximize future rewards, for example, the 
Probabilistic Reward Task (PRT), developed for human use 
(Pizzagalli et  al., 2005) and then for rodent use (Der-Avakian 
et al., 2013); (2) tests for the assessment of motivated behaviors 
where PR protocols and effort-related choice tasks have been 
translated from rodents for the use in human subjects; (3) tasks 
that assess the evaluation of rewards, such as the outcome 
devaluation task; and (4) tests that assess the affective condi-
tion of the subject, for example, the affective tone discrimin-
ation task, where the presence of a negative bias in emotional 
processing is examined (Der-Avakian and Pizzagalli, 2018). In 
some of these tasks (e.g., PRT, PR protocol, effort-related tasks), 
differences between the performance of control subjects and 
depressed and/or anhedonic subjects have been demonstrated 
both in humans and rodents (Der-Avakian and Pizzagalli, 2018). 
In some cases, the expected responses to pharmacological 
manipulations have been observed, for example, in the PRT 
and effort-related choice task, psychostimulant administration 
increases response bias and the choice for the high-effort/high-
reward option, respectively, in rodents (Der-Avakian et al., 2013) 
and humans (Wardle et al., 2011).
Thus, translational analogous tasks that investigate in 
humans and experimental animals different aspects of anhedo-
nia are important tools to develop potential treatments for the 
impaired reward processing. Moreover, their results can be ana-
lyzed by computational models, which allow the identification 
of neurobiological distinct subtypes within the heterogeneous 
symptom domain of anhedonia and can usher in targeted treat-
ment approaches (Cooper et  al., 2018). In fact, computational 
psychiatry is based on the idea that behavioral manifestations 
of clinical symptoms can be operationalized in terms of compu-
tational components allowing an objective assessment of clini-
cal behaviors. Computational methods such as modeling and 
translational assessments can be applied to make inferences 
regarding mechanisms that underpin the observed behavior in 
groups of psychiatric patients and reduce subjective interpre-
tations of behavioral responses to reward, both in experimen-
tal animals and humans (Cooper et al., 2018; Der-Avakian and 
Pizzagalli, 2018).
Advantages and Disadvantages of Rodent Models of 
Anhedonia
The CMS model is based on stressful environmental condi-
tions that aim to reproduce stressors that can negatively impact 
human life and is defined as one of the most valid animal mod-
els of depression. The model, or models since many variants 
of the original one are used, is best characterized for induc-
ing long-lasting impairments in reactivity to aversive stimuli 
(behavioral despair) and to reward (mainly assessed with the 
sucrose preference test, with the previous described limita-
tions). The limitations of the model are that it is time consuming 
and laborious, and these factors may underlay the low repro-
ducibility across different laboratories that has been reported, 
along with the experience of the experimenters, the severity of 
the applied stressors, and the conditions chosen for the evalu-
ation tests (e.g., the concentration of sweet solution utilized in 
the sucrose preference test). Variability in vulnerability to the 
stressors between mice and rat strains and within the same 
strain have been consistently found. However, this disadvantage 
could actually allow the selection of subgroups of susceptible 
and resilient animals to study the neurobiological mechanisms 
of susceptibility and resiliency.
Models based on chronic social stress induce a decrease in 
social behaviors in defeated rodents with social avoidance and 
responses to rewarding stimuli, and an increase in anxiety-like 
behaviors. The impairments induced by chronic social defeat 
on reward responses are observed in rats and mice, for exam-
ple, on ICSS, supporting the validity of this protocol to induce 
anhedonia in different species. On the other hand, the effects 
on reactivity towards aversive stimuli (behavioral despair) are 
less consistently observed; thus, these models are useful tools 
when “anhedonia” is the focus of the study and responses to 
social or nonsocial rewards can be evaluated. The effects of 
repeated treatments on the consequences of chronic defeat can 
be studied in these models. A disadvantage of these models is 
that they are not acute models and protocols may last several 
weeks (as for the CMS), with continued repeated exposure to 
social conflict or subthreshold stressors. Moreover, exposure to 
social stress models selects susceptible and resilient animals in 
a rodent population, more often and with a greater percentage 
of resilient animals than observed in the CMS model. This can 
be seen as an advantage of the model, since it is closer to the 
human condition where individual vulnerability interacts with 
adverse social environment to elicit depression onset and offers 
the possibility to investigate neurobiological characteristics of 
resilient animals.
Immune-mediated models, as well as studies of immune 
responses in exogenous stressors-induced models, can be used 
to verify whether activation of brain proinflammatory cytokine 
signaling represents the final common pathway for the various 
conditions that lead to a depressive-like phenotype. If this were 
proven to be the case, then these models can allow the identi-
fication of the molecular mechanisms that underlie the asso-
ciation between inflammation and depression and may suggest 
targets for the development of new antidepressant drugs. A lim-
itation of the immune-mediated models is that while repeated 
preventive treatments can be used (Jaehne et al., 2015), the rel-
atively short duration of the behavioral deficits after the chal-
lenge and waning of the sickness syndrome hinders long-term 
treatments. Although a long-lasting, anhedonic-like phenotype 
can be induced in mice, it is dependent on the strain, social 
environment, and probably sex (Painsipp et al., 2011), thus limit-
ing the possible applications of the model. Therefore, the use 
of exogenous stressor-induced models to investigate immune 
responses and their role in anhedonic/depressive like pheno-
type may offer a more flexible choice of the species, strain, sex, 
and environmental variables.
Conclusions
Animal models of mood disorders are valuable tools that allow 
the study of their neurobiological underpinnings and the search 
of possible predictors of treatment outcome. This is particularly 
true for anhedonia since the presence of unremitting reduced 
responses to positive stimuli correlates in patients with poor 
treatment response (Uher et  al., 2012), while early improve-
ments in positive affect predict a positive treatment outcome 
and discriminates between treatment responders and nonre-
sponders (Geschwind et al., 2011). Exposure to anhedonia mod-
els induces in rodents a collection of symptoms or behaviors, 
some unrelated to impaired reward responses (e.g., behavioral 
despair) and several concerning the domain of processing and 
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constructs of reward responses are available and validated, so 
we can examine the different steps, from the affective response 
to a sensory stimulus to the effort that the animal is willing 
to exert for a larger reward. Similar tests and tasks have been 
developed, or are under development, for clinical studies of 
impaired reward responses in patients. The progressive devel-
opment of translational assessment tasks allows to integrate 
the application of computational methods to identify different 
behavioral profiles within a heterogeneous symptom domain 
(Cooper et al., 2018). However, although it is possible to dissect 
the different components of the complex responses to a reward-
ing stimulus in an experimental set up, this can be difficult in 
real life situations, both in animals and humans. Moreover, one 
caveat to the translation of preclinical to clinical studies in the 
field of anhedonia is that the response to primary rewards (e.g., 
food) is examined when testing anhedonia in animal models, 
whereas studies in humans primarily use secondary rewards 
(e.g., money). Evidence indicates that the neurobiological 
response to a primary reward may not completely overlap with 
the response to a secondary reward (Sescousse et al., 2013).
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